| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $21.57B | $22.71B | $23.23B |
| YoY Revenue Growth % | -5.0% | -2.2% | — |
| Gross Profit | — | $19.59B | — |
| Gross Margin % | — | 86.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $3.04B | $6.27B | $5.54B |
| Operating Margin % | 14.1% | 27.6% | 23.9% |
| Net Income (GAAP) | $0 | $0 | $4.70B |
| EBITDA (Normalized) | $8.18B | $11.28B | $6.38B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $10.53B | $11.44B | $12.31B |
| Capital Expenditures (CapEx) | $6.43B | $6.26B | $1.05B |
| Free Cash Flow (FCF) | $4.11B | $5.18B | $11.26B |
| FCF Margin % | 19.0% | 22.8% | 48.5% |
| Return on Invested Capital (ROIC %) | 4.4% | 8.7% | 20.9% |
| Cash & Short-Term Equivalents | $1.97B | $2.13B | — |
| Total Debt (Short + Long Term) | $20.62B | $24.98B | $8.11B |
| Total Stockholders' Equity | $36.03B | $34.16B | $16.63B |